Editorials Dietary fibre and colonic function
There is nothing new about the fact that fibre affects bowel function. This observation was common knowledge in the Middle Ages and as far back as the time of the Roman Empire it was known that bread made from wholemeal flour increased faecal output when compared to that made from sieved flour. Why then is there currently so much interest in dietary fibre?
Fibre is now being widely used to treat large bowel disorders such as constipation, diverticular disease and the irritable bowel syndrome. There is therefore a need to know more about it: how it works and what its possible dangers might be. Also important is the suggestion that an adequate intake of dietary fibre may prevent development of these bowel problems and in addition protect us from large bowel cancer.
New methods for the measurement of dietary fibre (Southgate 1976 , Van Soest & McQueen 1973 developed in the past few years have radically changed our ideas about it. Hitherto dietary fibre has been equated with 'crude fibre', a term used by animal nutritionists to define material isolated from animal foodstuffs by a simple analytical technique which measures only part of the true fibre content. Modern methods of analysis coupled with physiological studies in man have made it clear that the concept of fibre should be much broader encompassing all the main plant cell wall constituents, i.e, cellulose, hemicellulose, pectin and lignin as well as biochemically related plant substances not found in the cell wall like the gums and mucilages (ispaghula, sterculia, guar, etc.) (Cummings 1976) . The crude fibre concept has no validity in human nutrition and in fact is quite misleading. However, the majority of papers and literature up to the present refer to crude fibre when fibre is mentioned.
Despite problems of analysis and definition, investigation into the colonic effects of fibre has progressed spasmodically for about fifty years. An almost universal finding is that increasing fibre intake increases faecal weight (Mitchell & Eastwood 1976) . Not surprisingly though, in view of the many possible sources of fibre and its heterogenous composition, this statement must be qualified. An individual when fed fibre in equal amounts from different sources will show a different increase in faecal weight for each fibre. Although there is not enough experimental data at the moment to illustrate this point adequately, wheat fibre (as in bran) produces a relatively large increase in faecal weight (Cummings et al. 1976) , whilst pectin increases faecal output only minimally (Durrington et al. 1976 ). Reports of work done forty years ago suggest that fibre from fruit and vegetables also has markedly contrasting effects on faecal weights (Williams & Olmsted 1936) . Whether a synergistic effect between different fibres on bowel habit occurs is not known. What is clear though is that the capacity of fibre to increase faecal weight varies from fibre to fibre and also from person to person.
How does fibre exert this effect on colonic function? In the early days of fibre research it was thought that the increase in faecal bulk (which is largely water) was due to production ofshort chain fatty acids (acetate, proprionate, butyrate) in the bowel from breakdown of fibre, which in tum stimulated colonic peristalsis and also held water in the lumen by osmosis (Williams & Olmsted 1936) . Today the suggestion that fibre increases faecal bulk through its capacity to hold water in a gel-like form is more widely accepted. Experimental proof of this is a waited.
Fibre is not an inert substance as was once believed. It is digested and metabolized in the large gut by colonic microflora. About 75 0 0 is broken down to short chain fatty acids, hydrogen, carbon dioxide, water and methane. The hemicelluloses and pectin (non-ceIlulosic polysaccharides) are digested to a greater extent than cellulose, with lignin being undigested (Southgate & Durnin 1970) . This digestive process alters the properties of fibre as it passes through the gut. The metabolites produced influence other metabolic processes.in the colo.n such as ammonia generation, bactenal metabohsm of drugs, food additives and other unabsorbed or secreted substances. Attempts to measure the effect of fibre on these colonic changes have not always been rewarding, in particular those looking at the role of fibre on the faecal microflora (Drasar et al. 1976 ). However, faecal excretions of fat, nitrogen, minerals and bile acids rise on adding fibre to the diet, the size of increase depending on the type of fibre added (Cummings et al. 1976 .
The time taken for food residues and other materials to pass through the gut, the transit time, is largely a colonic function. Transit time in young and middle aged people in Britain averages 2-4 days but is probably greater in the elderly. Of this only 12 hours can legitimately be considered gastric and small intestinal transit, leaving most of the time food residues spend in the gut to be spent in the colon. Fibre alters transit time. Again most of the evidence relates to wheat fibre but it has been shown on several occasions that bran shortens transit time when given in moderate amounts (15-30 g/day) (Cummings et al. 1976 , Payler et al. 1975 . The effect of other types offibre is in doubt at the moment but since in general transit time and faecal weight are related one would expect those fibres which produce only minimal increases in faecal weight to shorten transit time very little.
So much for the physiological effects of fibre in the colon; to what therapeutic uses have these actions been put? Fibre has been used in the treatment of constipation for many years (Cleave 1941,Jones & Godding 1972)and its continued use would seem to confirm its efficacyin this condition. Few formal studies to test this have been made, understandably so as faecal collections in constipated subjects require considerable devotion on the part of subject and investigator. There was some experimental interest in this aspect of fibre in the I940s and early 1950swhen several trials of the laxative effect of fibre were undertaken (Gray & Tainter 1941 , Tainter & Buchanan 1954 . These studies sought to establish the relative efficaciesof different types of fibre in relievingconstipation but because the available methods for measuring fibre and its constituents were inaccurate little emphasis can be placed on this aspect of the work. Many types of fibre were however shown to increase faecal weight. At the present time no one has drawn up a valid 'league table' for the faecal bulking effect of different fibres so further research is awaited. Meanwhile both earlier studies and present ones suggest that wheat fibre will prove to be one of the best bulking agents.
Several proprietary fibre preparations are currently available containing ispaghula, sterculia, bran, methylcellulose and psyllium which are marketed under about ten different brand names and these may also be used in the treatment of constipation. It is worth remembering that these proprietary medicines contain different types of fibre and therefore it should be possible to switch from one to another with benefit or even combine two contrasting types to get maximal effect 011 bowel habit. Patients should also be given appropriate dietary advice on how to increase their fibre intake. Whether there is any adaptation by the human colon to increased fibre intake in the long term thus rendering it progressively less effective remains to be established, as do any long-term problems with mineral balance.
Traditional dietary advice for diverticular dis. ease has been completely revised with the adven1 of fibre. Based on the hypothesis derived from epidemiological and experimental evidence that colonic muscular hypertrophy and diverticula ill this disease derive from the large bowel having tc mix and propel small volumes of desiccated 10\'\ residue material, it was decided to treat patient! with fibre to increase faecal bulk and soften the consistency of colonic contents. Initial studies gave favourable results using bran (Painter et al. 1972 . Findlay et al. 1974 , Brodribb & Humphreys 1976 ; and now a double-blind trial has confirmed the benefit of wheat fibre in this condition (Brodribt 1977) . Not all patients benefit from the regime 01 are able to modify their diets sufficiently to in. crease their wheat fibre intake. Others get ar increase in abdominal discomfort and bowel dis. turbance initially which discourages them. Overal though fibre now has a place in the treatment os ymptomatic diverticular disease. These expefi, mental studies have shown that an increase it faecal bulk occurs, transit time is shortened anc abnormal intraluminal pressure patterns are modi fied. There is however a great deal of variation it the response of individual patients which give! scope for further work.
A clear role for fibre in the treatment of tlu irritable bowel syndrome is less easy to define. A number of trials have now been reported, SOm, describing beneficial effects and others not (Seltof et al. 1976 , Weinreich 1976 , Manninget al. 1977 The main problem with the investigation of thi: condition is its diverse nature. At least two clearl1 defined symptom patterns are recognized: painle& diarrhoea; and abdominal pain with an irreguIa bowel habit -and there are many variants 01 these. Not only are the symptom patterns variabl, but the primary disturbance of gastrointestina function causing the condition has not been clearl1 identified and indeed the irritable bowel syndrorn; may in fact be a group of diseases with severa different aetiologies. These things conspire t( make clinical trials in this condition difficult. Many physicians feel, however, that little harm is done in trying fibre.
Beyond the value of fibre as a therapeutic agent in colonic conditions lies its role in the prevention of large bowel disease. This is an area where, not surprisingly, theories abound but conclusive evidence is lacking. Since the two main diseases in question, diverticular disease and large bowel cancer, are essentially chronic conditions thought to develop over many years the cause of them is difficult to identify. The evidence suggesting fibre exerts a protective role in both diseases is largely epidemiological (Painter & Burkitt 1971 , Burkitt 1971 , Burkitt et al. 1972 ) and is far from conclusive.
For diverticular disease the hypothesis linking low fibre intakes to pathological changes in the colonic wall assumes that these changes develop in response to a dietary deficiency. Whilst an association of what are likely to be low fibre diets with a high incidence of diverticular disease in certain countries can be demonstrated it is much more difficult to be sure that it is causal. Subjects with pre-diverticular disease and hence on prediverticular diets cannot be identified very easily. Furthermore, the true prevalence of colonic diverticula is difficult to measure unless widespread Xray examinations are performed on the general population. Also no published data of actual dietary fibre intakes in relation to diverticular disease exist, mainly because measurement of dietary fibre intakes epidemiologically has only become possible in the past year or so. The epidemiological data needs to be clarified a lot more before the true role of fibre in the development of diverticular disease is established.
With colon cancer the prize is much greater if a protective role can be assigned to fibre. The possibility that colon cancer might be environmental in origin and in particular related to diet has stimulated much research in recent years. Epidemiological evidence strongly implicates dietary fat and animal protein as a cause of this cancer (Hill 1975) whilst fibre, through its effect on colonic function and microbial metabolism, may be protective. The dietary data for fat and protein intakes are relatively good but for fibre are almost nonexistent. This is not to say that fibre intakes may not in fact be low in areas where colon cancer incidence is high but that they have not been measured. The suggested association of higtt fibre intakes with low risk of colon cancer as it stands at present is based on personal observations. First reports are now starting to appear in which this specific relationship has been looked for and measured using up-to-date techniques and these observations do in fact support the concept of a protective role for fibre (lARC 1977) . More data are required.
Many animal experiments testing the dietary hypothesis for colon cancer have also been completed and lend strong support to the hypothesis. What is not yet clear is the precise carcinogen involved in the initiation of this cancer (degraded bile acids have been implicated but not proven) and what dietary measures would be appropriate to prevent its formation or activation. When this is known it should be possible to recommend changes in our diet with the aim ofpreventing this and other colonic diseases, though if the response to the 'no smoking' campaign is any guide, the path to good health by means of a high fibre diet looks both narrow and uphill. 
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Infectionin the renal transplant patient
Renal transplantation has now been accepted therapy for chronic renal failure for over a decade (Kincaid-Smith 1971 , Hulme 1975 but two outstanding problems remain: rejection of the graft and infection in the recipient. Graft survival is sometimes purchased only at the expense of patient wellbeing, mainly because of the unselective immunosuppressive effects of azathioprine and corticosteroids. Severe infection is in fact the commonest cause of death in transplant recipients (Rifkind et al. 1967 , Hill et al. 1967 , Parsons et al. 1971 , Myerowitzet al. 1972 , Parsons et al. 1975 ,Gurland et al. 1976 .
A changing pattern of infection has emerged since the early days of transplantation when, due to a general lack of dialysis support, a transplant was often the only alternative to death in uraemia. In early series, bacterial and fungal infections contributed almost equal numbers of deaths, and mortality from Pneumocystis carinii and other protozoal infection was considerable. Hill et al. (1967) analysed the cause of death in 60 of 113 patients transplanted between 1962 and 1965. Of the 'late' deaths (after twenty-seven days) 86 0 0 were due to sepsis, and in almost half (21 of 46) fungal infection was primarily responsible. Rifkind et al. (1967) in a follow-up study of III patients over 3-40months found that 55 had died, and postmortem examination revealed systemic fungal infection in 23. The predominant fungi were Candida albicans and Aspergillus fumiqatus, often together, and it was stated that 'fungi and parasites have become pre-eminent as infecting agents'. In reporting 51 cadaver transplants performed between 1961 and 1971, Bach et 01. (1973) found that, in their series, death from Aspergillus fumiqatus was more common than from bacterial sepsis, but believed this to be contrary to general experience. In more recent reports (Hall et 01. 1976) bacterial infection, usually with Gram-negative organisms, has greatly predominated over fungal infection as the main cause of death.
In 54 patients transplanted at the Royal Free Hospital from February 1975 to July 1976, eight died, six due to sepsis. In none did post-mortem reveal a systemic mycosis.
The main factor in the control offungal infection is probably the shorter duration of high-dose corticosteroid therapy (> 40 mg/day prednisone) now used to prevent rejection. Anderson et 01. (1973) showed that important risk factors in immunosuppressed patients included neutropenia, a moderate to severe degree of graft failure, with creatinine clearance less than 40 rnl/min, and most significantly (P < 0.00 I) hyperglycaemia, defined as fasting blood sugar greater than 120 mg/IOO ml, Hypergiycaemia is often the result of high-dose steroid therapy, and both predispose to fungal infection. In Rifkind's patients (Rifkind et 01. 1967) , clinical fungal infection occurred on average 67 days after transplantation, when the average dose of prednisone was 60 mg/day, whilst bacterial infection usually occurred in the first sixty days. Bach et al. (1973) related their high incidence of fungal infection to the number of treated rejection episodes. During 1969/70 these were managed by increasing prednisone to 320 mg/day for the first week, then halving the dose weekly until maintenance levels were reached. They thus employed highdose steroid therapy for four weeks. During 1971 rejection episodes were treated with seven daily I gram doses of intravenous methylprednisolone, with no increase in oral prednisone dosage. The patients treated by short-term increase of oral prednisone had significantly more fungal and nocardial infections, which were further increased if treated rejection episodes were multiple or occurred more than 30 days after transplantation. 60 0 0 of the systemic fungal infections developed within 42 days of rejection although, as the authors pointed out, fungal infections may occur long after this period.
Pneumocystis carinii infection is also associated with high-dose steriod therapy (Rifkind et al. 1967) . At post-mortem, 10 of 51 patients had developed pneumocystis pneumonia 69-599 days after transplantation. These patients had received high-dose steroid therapy for a mean of 113days as compared to 49 days for all fatal cases. In contrast, no pneumocystis infection occurred in the 54 Royal Free patients, and in only I of 40 deaths in another series (Hall et aI. 1976) . Three conclusions may therefore be drawn: (I) Fungal/parasitic infections tend not to occur until several weeks after a transplant. (2) Prolonged or frequent intermittent high-dosage steroid therapy predisposes to
